Results of a new study “support the therapeutic potential of cannabinoids in patients with OSA [obstructive sleep apnea]”. For the study, published in the journal Sleep and epublished ahead of print by the National Institute of Health, “73 adults with moderate or severe OSA received either placebo (N=25), 2.5mg dronabinol (N=21) or 10mg dronabinol (N=27) daily, one hour …
Tag: sleep apnea cannabinoids
- First-ever First Nation cannabis outdoor grow operation; First Nation cannabis inventor and entrepreneur featured in second edition of “Growth and Prosperity” Magazine
- Wiisag Receives Confirmation of Readiness for Outdoor Cannabis Cultivation
- Arkansas First Ever Medical Marijuana Dispensary Now Open
- Medical Marijuana vs. Recreational Marijuana
- How Does Medicare Cover Arthritis?
- Florida Legislature Approves Bill to Establish Agricultural Hemp Program
- Study: Most Health Professionals (Doctors, Pharmacists and Nurses) Support Medical Marijuana
- Canada: Marijuana Body Gives Recommendations to Boost Industry
Thank you for reading TheJointBlog.com!